A detailed history of Prio Wealth Limited Partnership transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 91,794 shares of EW stock, worth $6.01 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
91,794
Previous 92,094 0.33%
Holding current value
$6.01 Million
Previous $8.8 Million 3.65%
% of portfolio
0.26%
Previous 0.26%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 10, 2024

SELL
$84.3 - $94.31 $25,290 - $28,293
-300 Reduced 0.33%
91,794 $8.48 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $36,560 - $48,162
-504 Reduced 0.54%
92,094 $8.8 Million
Q4 2023

Jan 22, 2024

SELL
$61.71 - $77.76 $493 - $622
-8 Reduced 0.01%
92,598 $7.06 Million
Q3 2023

Oct 31, 2023

SELL
$69.28 - $93.38 $108,561 - $146,326
-1,567 Reduced 1.66%
92,606 $6.42 Million
Q2 2023

Aug 08, 2023

SELL
$81.41 - $94.33 $79,293 - $91,877
-974 Reduced 1.02%
94,173 $8.88 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $68,839 - $78,340
-927 Reduced 0.96%
95,147 $7.87 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $1.82 Million - $2.33 Million
-26,701 Reduced 21.75%
96,074 $0
Q3 2022

Feb 27, 2023

SELL
$82.37 - $107.29 $936,711 - $1.22 Million
-11,372 Reduced 9.67%
106,251 $8.78 Million
Q2 2022

Feb 27, 2023

BUY
$86.5 - $128.27 $1.86 Million - $2.76 Million
21,549 Added 22.43%
117,623 $11.2 Million
Q1 2022

Feb 21, 2023

BUY
$101.96 - $128.34 $2.42 Million - $3.05 Million
23,739 Added 24.71%
119,813 $14.1 Million
Q4 2021

Feb 17, 2022

SELL
$106.37 - $130.68 $244,757 - $300,694
-2,301 Reduced 1.84%
122,775 $15.9 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $123,389 - $147,177
-1,199 Reduced 0.95%
125,076 $14.2 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $234,500 - $293,013
-2,797 Reduced 2.17%
126,275 $13.1 Million
Q1 2021

May 06, 2021

SELL
$78.68 - $90.67 $767,130 - $884,032
-9,750 Reduced 7.02%
129,072 $10.8 Million
Q4 2020

Feb 04, 2021

SELL
$71.69 - $91.23 $423,831 - $539,351
-5,912 Reduced 4.08%
138,822 $12.7 Million
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $168,982 - $219,911
-2,515 Reduced 1.71%
144,734 $11.6 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $5.62 Million - $7.52 Million
97,719 Added 197.29%
147,249 $10.2 Million
Q1 2020

May 13, 2020

SELL
$52.41 - $81.0 $126,360 - $195,291
-2,411 Reduced 4.64%
49,530 $9.34 Million
Q4 2019

Feb 10, 2020

SELL
$71.7 - $82.09 $50,978 - $58,365
-711 Reduced 1.35%
51,941 $12.1 Million
Q3 2019

Nov 13, 2019

SELL
$61.55 - $75.43 $3.28 Million - $4.02 Million
-53,297 Closed
0 $0
Q2 2019

Jul 18, 2019

SELL
$55.74 - $64.41 $177,699 - $205,339
-3,188 Reduced 5.64%
53,297 $9.85 Million
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $59,144 - $79,101
-1,235 Reduced 2.14%
56,485 $10.8 Million
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $28,913 - $35,473
623 Added 1.09%
57,720 $8.84 Million
Q3 2018

Nov 07, 2018

SELL
$45.7 - $58.03 $41,038 - $52,110
-898 Reduced 1.55%
57,097 $9.94 Million
Q2 2018

Aug 06, 2018

SELL
$42.45 - $51.3 $63,038 - $76,180
-1,485 Reduced 2.5%
57,995 $8.44 Million
Q1 2018

Apr 17, 2018

BUY
$37.19 - $47.45 $2.21 Million - $2.82 Million
59,480 New
59,480 $8.3 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.